DB-3Q for the Treatment of Medically Refractory Crohn's Disease

NCT07625293 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease (CD)

Interventions

BIOLOGICAL: DB-3Q
OTHER: Placebo

Sponsor

Direct Biologics, LLC